Home
Amneal Pharmaceuticals AMRX paid Tarplin, Downs & Young $60K for lobbying in Q3 2024 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q3 2024
- Client
- Amneal Pharmaceuticals
- Reported
- 24/10/18
Up 0.0% from last quarter
What else happened in Amneal Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/08/31~24/10/30Amneal Pharmaceuticals's other lobbying reports
- Amneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
AMRX
$190K
$190K
Reported 07/20
for Q2
- Amneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
AMRX
$20K
$20K
Reported 07/17
for Q2
- Amneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
AMRX
$60K
$60K
Reported 07/16
for Q2
- Amneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
AMRX
$190K
$190K
Reported 04/20
for Q1
- Amneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
AMRX
$60K
$60K
Reported 04/20
for Q1